Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Sodium alginate - Escherichia coli 2-052-05_S4_C3 |
👶
Development of Luteolin-Loaded Calcium Alginate and Gum Tragacanth Blend Microbeads for Oral Delivery: In Vitro Characterization, Antioxidant, Antimicrobial, and Anticancer Activity Against Colon Cancer Cell Line (HT-29). Assay and drug development technologies (Assay Drug Dev Technol ) Vol: Issue Pages: Pub: 2025 Apr 4 Epub: 2025 Apr 4 Authors Zafar A , Alsaidan OA , Mujtaba MA , Sultana S , Publication |
| Sodium alginate - Escherichia coli 2-052-05_S4_C3 |
👶
Biomacromolecular composite microspheres based on sodium alginate and tremella fuciformis polysaccharide for enhanced protection and delivery of camellia oil: A comprehensive study in simulated digestion. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 310 Issue Pt 4 Pages: 143481 Pub: 2025 Apr 24 Epub: 2025 Apr 24 Authors Cai Y , Xu P , Huang R , Huang J , Zhan J , Su J , You R , Lu Y , Publication |
| Sodium alginate - Escherichia coli 2-052-05_S4_C3 |
👶
Anti-proliferative, antimicrobial, DFT calculations, and molecular docking 3D scaffold based on sodium alginate, chitosan, neomycin sulfate and hydroxyapatite. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 270 Issue Pt 1 Pages: 132297 Pub: 2024 Jun Epub: 2024 May 12 Authors Dacrory S , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
